Moderna, Inc.
USD72.79
+3.09 (+4.43%)
CEO
Stéphane Bancel
IPO Date
2018-12-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$69.83
Prev. Close
$69.70
Day Low
$69.83
Day High
$73.18
52W Low
$22.28
52W High
$73.18
Market Cap
$28.88B
Volume
1.94M
| -4.5 |
| 31 Dec 2023 | FY | 31.5% | -68.8% | -34.0% | -25.6% | 0.09 | 3.42 | -8.1 |
| 31 Dec 2022 | FY | 71.3% | 44.3% | 43.7% | 32.3% | 0.06 | 2.73 | 8.5 |
| 31 Dec 2021 | FY | 85.2% | 68.8% | 86.3% | 49.5% | 0.06 | 1.76 | 8.4 |
| 31 Dec 2020 | FY | 95.1% | -93.0% | -29.2% | -10.2% | 0.09 | 1.43 | -53.3 |
| 31 Dec 2019 | FY | 48.5% | -853.7% | -43.8% | -32.3% | 0.11 | 7.89 | -12.6 |
| 31 Dec 2018 | FY | 81.6% | -284.8% | -25.1% | -19.6% | 0.02 | 7.02 | -13.1 |
| 31 Dec 2017 | FY | 90.0% | -124.3% | -40.9% | -23.6% | 0.03 | 4.09 | -27.3 |
| 31 Dec 2016 | FY | 86.1% | -199.5% | -25.7% | -15.3% | 0.01 | 6.68 | -5.5 |
| -3.5 |
| 30 Sept 2025 | Q3 | 0.8% | -19.7% | -2.1% | -1.6% | 0.15 | 3.93 | -12.6 |
| 30 Jun 2025 | Q2 | 16.2% | -581.0% | -8.8% | -6.9% | 0.08 | 3.93 | -3.2 |
| 31 Mar 2025 | Q1 | 15.9% | -907.5% | -9.6% | -7.6% | 0.07 | 4.22 | -2.8 |
| 31 Dec 2024 | Q4 | 22.7% | -117.2% | -10.3% | -7.9% | 0.07 | 3.67 | -3.6 |
| 30 Sept 2024 | Q3 | 72.3% | 0.7% | 0.1% | 0.1% | 0.11 | 4.39 | 494.8 |
| 30 Jun 2024 | Q2 | 48.0% | -578.7% | -10.9% | -8.2% | 0.11 | 4.09 | -8.7 |
| 31 Mar 2024 | Q1 | 42.5% | -703.6% | -9.2% | -7.0% | 0.10 | 4.03 | -8.6 |
| 31 Dec 2023 | Q4 | 67.0% | 7.7% | 1.6% | 1.2% | 0.09 | 3.42 | 43.7 |